FindTrial
Sign In

Clinical characteristics and outcomes of novel coronavirus pneumonia (COVID-19) patients with pre-existing HBV infection

Clinical characteristics and outcomes of novel coronavirus pneumonia (COVID-19) patients with pre-existing HBV infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033107
Enrollment
Unknown
Registered
2020-05-21
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:None

Sponsors

Department of Gastroenterology, Daping Hospital, Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Consecutive COVID-19 patients who was confirmed by high-throughput sequencing or real-time reverse transcriptase-polymerase chain reaction assay of nasopharyngeal swab specimens from Huoshenshan hospital, Tongji Taikang hospital and Guanggu branch of maternal and child health hospital; 2. Patients with pre-existing HBV infection.

Exclusion criteria

Exclusion criteria: 1. Patients was diagnosed with tumor; 2. Pregnant women or minors aged <18 years; 3. Long - term treatment against hepatitis b virus; 4. Patients with severe chronic end-stage disease, such as severe heart failure, COPD, or uremia, underwent dialysis; 5. Patients who were considered inappropriate to be included in the analysis by researchers.

Design outcomes

Primary

MeasureTime frame
mortality;—

Countries

China

Contacts

Public ContactChen Dongfeng, Wen Liangzhi

Department of Gastroenterology, Daping Hospital, Army Medical University

Chendf1981@126.com+86 13883032812, 17782366108

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026